Merck, Schering Settle Vytorin Zetia Class Action
Merck and Schering Plough have entered into $41.5 million settlement of class action lawsuits related to claims against their shared cholesterol medication Vytorin and Zetia.
The suit revolved around allegations that the results from the Enhance Trial raised questions about the efficacy of the Zetia and Vytorin.
The settlement will resolve approximately 145 lawsuits pending in federal court that seek economic damages related to the purchase of the cholesterol drugs.
AUG-05-09: Merck, Schering in $41.5 mln drugs settlement [REUTERS: MERCK, SCHERING SETTLE VYTORIN, ZETIA SUITS]
If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.
Related Law Suits
Merck, Schering Law Suit and Settlement
Schering Plough, Merck Law Suit and Settlement
$3.78 Million Dilantin Settlement Following Death of 9-Year-Old Girl Law Suit and Settlement
Airborne Settlement Law Suit and Settlement
Zyprexa Settlement Law Suit and Settlement
GSK Paxil Law Suit and Settlement
Wyeth Law Suit and Settlement
82 Year Old Law Suit and Settlement
Insurers Law Suit and Settlement
Unsuitable Blood Law Suit and Settlement
See more stories from this source.
Class Action Law Suits
Newsworthy Law Suits
Defective Products Lawsuits
Drug & Medical Claims Lawsuits
Food & Dietary Supplement Lawsuits
Personal Injury Lawsuits
Real Estate Lawsuits
Investment Fraud Lawsuits
Related Law Articles
Related Law Questions
Related Law Bulletins
Lawyers! Become an Approved Expert to Answer Questions.
You'll get lots of targetted traffic to your website and new client leads!